Oncotarget contribution to science and breast cancer prevention

According to Oncotarget, Particular negative breast cancer cells positively react to therapy involving hormones given they show an estrogen receptor beta protein as well as reveal other molecules expected to develop breast cancer drugs. The breast cancer cells contain types of progesterone and or estrogen hormones that contribute to their growth. The absence of receptors for these hormones causes resistance to hormonal treatment which causes Triple Negative Breast Cancer. Follow Oncotarget on Twitter.

Patients with this condition are underprivileged since cancer can spread to other body organs. The Mayo Clinic researchers found out that the TNBC cells with no estrogen alpha receptor could be decelerated with estrogen chemicals if the cells show another estrogen receptor. They also found that estrogen could prevent tumor growth if the cells got expressed, and estrogen impact on estrogen receptor beta protein is because of cyclin-dependent kinases, proteins that control the cell division. Download output styles at Endnote.com

The researchers’ preliminary study observed that TNBC patients lacking estrogen receptor alpha proteins have high endurance rate and capable of becoming cancer free. Oncotarget is a public biomedical journal. It researches on oncology and beyond Including immunology, aging, microbiology, autophagy, chromosomes, and pathology.

Oncotarget currently publishes two productions a week accessible on top most scientific research catalogs and other documents as well as in PubMed. The Oncotarget team announced to the readers its commitment to consistently make available their publications in PubMed and relevant archives and indexes. In association with National Library of Medicine, it is attaining its goal of being the first research journal to post to PubMed complete findings immediately after publishing.

Oncotarget association with high profile researchers has enabled them to make the prompt availability of their scientific findings to medical practitioners, field researchers, and the public. It has since 2010 produced 324 publications and it is now in the eighth volume. It gives a Direct Object Identifier to every paper and applies the committee recommendations on public ethics. The Oncotarget mission is to remain a prominent academic journal recognized for its rapid and extensive spread bio-medical research. It Strives to fight disease and by assisting researchers to contribute to the development of science.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/

Oncotarget – A Complete Review

Being a medical student, I was always interested in finding a resourceful online platform where I could get factual information on various medical fields especial cancer. It is true that finding a reputable website nowadays is not easy due to the infiltration of quarks in this field that do not provide accurate information. When a friend introduced me to the Oncotarget, I was amazed by the quality of work that I found on this website. The vast coverage of different fields especially cancer by their journals was incredible, and I have been following them up to date.

Oncotarget is a peer-reviewed journal that focuses on the pathological basis of all cancers. The journal provides the latest information on therapies and other treatment protocols that can be employed to enhance the management of cancer. The website is well known for publishing research papers in cancer research and oncology. Oncotarget, which is published by Impact Journals

It provides the leaders with the latest research on how to prevent, diagnose and treat cancer. Apart from the cancer research papers, the journal also publishes papers in the fields of physiology, immunology, pathology endocrinology and age-related diseases. This ensures that it has gone beyond cancer by covering areas that could have a direct or indirect impact on the cancer patient.

What I like most about Oncotarget is the frequency of the publications. They do weekly publications, and this is what keeps them evergreen. There is always new information and possibly update info on how to prevent, diagnose and prevent cancer. The authors are top quality, and any information that is posted on this website is certified and beyond reproach. I would really recommend med students and med practitioners to sign in to Oncotarget. Download output styles at Endnote.com.